Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Clinical Trial to Evaluate the Effects of an Omega-3-containing Supplement on DHA and EPA Levels in the Blood
Sponsor: Revive Active
Summary
This is a 12-week, hybrid, single-arm clinical trial designed to evaluate the effects of an omega-3-containing supplement (Omega Active) on DHA and EPA levels in the blood. Forty participants will take two capsules of the test product daily and complete study-specific questionnaires at Baseline, Week 4, Week 8, and Week 12, while also attending their local Quest Diagnostics Center at Baseline and Week 12 for blood biomarker testing. The study will also assess participants' perceptions of the effects of the test product on cognitive performance, gastrointestinal symptoms, and overall health through self-reported questionnaires. There is no randomization or blinding; all participants will receive the active supplement for the full 12-week intervention period.
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
49
Start Date
2026-09
Completion Date
2026-12
Last Updated
2026-08-07
Healthy Volunteers
Yes
Interventions
Omega Active Supplement
All participants receive one dose (two capsules) of the Omega Active omega-3 supplement daily for 12 weeks.
Locations (1)
Citruslabs
Las Vegas, Nevada, United States